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ABSTRACT
Objective: Although breath-holding spells (BHS) are the most common form of non epileptic paroxysmal events in infancy, 
the pathophysiology of these events remain unknown. Several studies have indicated that multiple factors can be involved 
in the pathogenesis of BHS. The aim of this study was to assess the associations between BHS and serum magnesium and 
calcium levels.
Materials and Methods: This prospective, case-control study enrolled 79 consecutive children with BHS and 114 healthy 
children, who were included as controls, without any illness between October 2012 and January 2014. Mean hemoglobin 
(Hb), mean corpuscular volume, serum iron, serum iron binding protein, magnesium(Mg), calcium(Ca), phosphorus (P), and 
alkaline phosphatase levels and Ca/Mg ratiowere compared between the two groups.
Results: Overall, the Hb, Ca, and P levels were in the normal range in both groups; however, the mean Hb, Ca, and P levels 
were significantly lower in the BHS group than in the control group. Furthermore, there was no significant difference in the 
mean serum Mg level or Ca/Mg ratio between the groups.
Conclusion: Therefore, low Hb, Ca, and P levels may decrease the threshold of BHS and thus constitute a risk factor for 
the development of BHS.
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INTRODUCTION
Breath-holding spells (BHS) are the most common form of non epileptic paroxysmal events in infancy,yet to 
date, their precise etiopathogenesis remains unknown. Genetic and environmental factors, such as micronutri-
ent deficiency and immunologic reactions, are thought to be involved inthe pathophysiology of BHS. BHS most 
commonly begins during the first 18 months of life, and most children outgrow BHS by the age of 6 years (1).
Although BHS is benign and the prognosis is excellent, the phenomena can be rather frightening for parents. 
Serious complications of BHS are rare, but cases of sudden death, prolonged asystole, and status epilepticus have 
been reported. A detailed history and examination are important to successfully diagnose BHS and help distinguish 
it from epileptic seizures and other causes of syncope (2).
The pathophysiology of BHS is not well understood. Some investigations have revealed significantly lower serum 
iron (SI) levels in patients with BHS than in healthy children (2, 3). However, Saad et al. (1) showed significantly 
decreased seleniumlevels in children withBHScompared to healthy controlsHowever, among the majority ofstudies 
conducted regardingBHS, autonomic dysregulation has consistently been postulated to have an important role in 
its pathophysiology (4-6).
Autonomic dysregulation leads to alterations in cardiac function resulting in brain hypoperfusion, seizure, and loss 
of consciousness. Heart rate variability (HRV), which controls cardiac function via efferent fibers to the vasculature 
of the heart as well as the sinoatrial node and myocardium, is an important marker for autonomic dysregulation 
(4, 6, 7). Serum electrolyte levels, including sodium(Na), potassium (K), calcium (Ca), and magnesium (Mg), can 
affect HRV directly by influencing cardiac muscle excitability and heart rate and indirectly by modifying blood pres-
sure (8,9). In addition, several authors have suggested that both Ca and Mg levels are involved in cardiovascular 
diseases, including sudden cardiac death (10, 11).
Mg, a natural antagonist of Ca, is an essential element in the regulation of circulation and plays a role in numerous 
enzymatic processes in the cardiovascular system. Therefore, Mg affects pivotal cardiac functions, including cardiac 
contraction, beating rhythm, vasomotor control, and proliferation of smooth muscle cells in vessels. However, 
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studies elucidating the influence of Mg and Ca on the autonomic 
nervous system are relatively rare. Murasato et al. (12) suggested 
that Mg deficiency induces sympathetic excitation and enhances 
the sensitivity of the sinus node to autonomic regulation. Further-
more, Devisetty et al. (13) found that decreased serum Ca levels 
causes disturbances in the autonomic nervous system.Although 
BHS are closely related to autonomic dysfunction and Mg and Ca 
are suspected to have effects on autonomic functions, there areno 
studies reporting the relationship between serum Mg and Ca levels 
in BHS. Therefore, the aim of the present study was to assess the 
relationship between BHS and serum Mg, Ca, and P levels as well 
as Ca/Mg ratio in patients in a single institution in Adana, Turkey.
MATERIALS and METHODS
All consecutive children admitted to Baskent University, Dr. Turgut 
Noyan Teaching and Medical Research Center Adana Hospital, 
Adana, Turkey, between October 2012 and January 2014 with or 
without BHS were eligible to participate. Patients with sepsis and 
signs of central nervous system infection or any confirmed neu-
rological illness; cardiac, hepatic, renal, or endocrine impairment 
or pulmonary disease; and developmental delay and regular blood 
transfusion were excluded. Informed consent was obtained from 
the parents of the participants.
Based on these criteria, 193 patients were enrolled. The BHS 
group comprised 79 children with BHS (43 boys and 36 girls; 
mean age, 2.0±1.3 years; range, 0.5–6.0 years) and the control 
group comprised 114 healthy children (52 boys and 62 girls; mean 
age, 2.0±1.2 years; range, 1–5.3 years) with a similar age distribu-
tion.
All patients in the BHS group underwent a comprehensive clinical 
evaluation. Each participant underwent a diagnostic examination 
with clinical and laboratory techniques. Electroencephalography 
(EEG) was performed when clinically indicated. In children with 
BHS, the frequency of episodes, type of BHS at presentation, 
history of BHS in their family, onset time of BHS, and findings 
regarding any underlying illness, and frequency of BHS episodes 
were recorded.
The control group participants had normal clinical and laboratory 
findings.
All participants had a single fasting blood sample drawn from the 
antecubital vein within 24 h after admission. Fasting time ranged 
from 4 h to overnight. Laboratory testing included complete blood 
count; serum iron, serum iron binding protein (SIBP), Mg, Ca, P, 
and alkaline phosphatase (ALP) levels; and Ca/Mg ratio. Serum 
testing was performed using chemiluminescent microp article im-
munoassay using a commercial kit (Abbott Laboratories, Abbott 
Park, IL, USA) and an Abbott Architect I2000 system (Abbott 
Laboratories).
Anemia was defined as hemoglobin (Hb) level below the normal 
range for age (<11 g/dL for age range 6 months–4 years; <11.5 
g/dL for age range 5−7 years). The age-based normal ranges for 
mean corpuscular volume (MCV) is70−76 f/L for age range6 
months–2 years, 73–75 f/L for age range2−4 years, and 75–95 
f/L for age range5–7 years (13).
The normal ranges for biochemical parameters were as follows: 
the age-based normal range for serum Mg is 1.6–2.6 mg/Dl for 
7 days–2 years and 1.5–2.3 mg/dL for 2–14 years and the age-
based normal range for serum P was 3.8–6.5 mg/dL for 1–3 years 
and 3.7–5.6 mg/dL for 4–11 years. The normal range for serum 
Ca is 8.8–10.8 mg/dL (13).
The mean results for Hb levels; hematocrit (htc) levels; MCV; white 
blood cell (WBC) count; red cell distribution width (RDW); platelet 
count; SI; serum ıron bonding protein (SIBP); Mg, Ca, P,ALP lev-
els; and Ca/Mg ratio were compared between the groups.
Statistical Analysis
Data were analyzed using Statistical Package for the Social Sci-
ences (SPSS version 17.0. IBM, USA). Measurements were sum-
marized as mean±standard deviation (and, where necessary, me-
dian and minimum–maximum). Distributions were checked when 
comparing continuous measurements between groups. Student’s t 
tests were used when parametric test assumptions were provided, 
and Mann–Whitney U test was used when assumptions were not 
provided. In the study, the area under the ROC curve was calcu-
lated using sensitivity and specificity values to determine threshold 
values for serum Mg and Calevels. The statistical significance was 
set at p<0.05.
RESULTS
The ages and genders of the participants in the BHS group and the 
control group were similar (p>0.05) (Table 1).
Of the 79 children with BHS, 71 (90%) were diagnosed with cya-
notic type and (10%) with pallid type; 6 (8%) had a family history of 
BHS; and 55 (70.0%) had recurrent attacks, who were evaluated 
using EEG: One patienthad an EEG abnormality consistent with 
epileptiform discharges and the EEG studies were normal in the 
remaining 54.
The mean Hb levels; MCV; SI; SIBP; serum Mg, Ca, P levels; 
and Ca/Mg ratioin the BHS and control groups are presented in 
Table 1. When these findings were compared, the only significant 
differences between the two groups were in Hb, Ca, and P levels. 
Although Hb levels were in the normal range in both groups, the 
mean Hb levels were significantly lower in the BHS group than in 
the control group (Table,p=0.03). However, no significant differ-
ences were found in the mean SI and MCV levels between the two 
groups (p>0.05). Furthermore, the number of anemic patients was 
also similar in the BHS and control groups (20 patients (25.3%) 
in the BHS group and 24 patients (32.0%) in the control group). 
When serum Ca and P levels were compared, both levels were in 
the normal range in both groups, but mean serum Ca and P lev-
els were significantly lower in the BHS group than in the control 
group (Table 1, p=0.001, p=0.007, respectively; figures 1 and 
2).There were no significant differences in either mean serum Mg 
levels or Ca/Mg ratio between the BHS and control groups (Table 
1, p=0.189, p=0.403, respectively; figures 3 and 4).
DISCUSSION
The main finding of the present study was that children with BHS 
had significantly lower mean serum Ca and P levels than those 
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without BHS. Furthermore, no differences were observed with re-
spect to Ca/Mg ratio or serum Mg and SI levels, although the 
mean serum Hb levels differed significantly between the groups.
BHS is a common non epileptic paroxysmal disorder in infancy 
and most commonly begins during the first 18 months of life, with 
an incidence of 4.6%–4.7% in the total population and a male to 
female ratio of 3:1 (14, 15).Nearly all children out grow BHS by 
the age of 6 years, and the persistence of BHS beyond 6 years is 
extremely rare. Consistent with previous reports, we found that 
the mean age of occurrence of BHS was 2.0±1.3 years with no 
significant difference between girls and boys (15, 16). In a previous 
study, a family history of BHS was found in 20%–30% of children 
with BHS (17, 18). Di Mario et al. (18) hypothesized that a consid-
erable BHS cases that had a family history of these events are pos-
sibly because of autosomaldominant inheritance with incomplete 
penetrance. In contrast to the study Di Mario et al. (18), only 8% 
of patients in the present study had a family history of BHS in a 
firstdegree relative.
BHS occurs when a child has had a minor accident or a frightening 
experience after which the child cries and holds his or her breath. 
Based on the child’s coloration during the spell, BHS is classified 
as “pallid type” if there is a powerful cardiac inhibition with a slight 
respiratory effect and as “cyanotic type” if there is an intense re-
spiratory inhibition with a slight cardiac effect (18, 19). However, 
occasionally children experience a mixed type, indicating that the 
pathogenesis of both types is similar. Furthermore, it has been 
found that cyanotic BHS are more common than pallid BHS. Cya-
notic BHS has been reported in 54%–62% of cases, pallid BHS 
has been reported in 19%–22% of cases, and mixed or unclassifi-
able BHS has been reported in 19%–24% of cases (18, 20).In the 
present study, 90% of children had cyanotic spells, which was a 
higher proportion than previously reported.
The mechanism of BHS is not fully understood and is most likely 
multifactorial. Several studies have examined the potential roles 
of iron, anemia, and changes in trace element contents in biologi-
cal fluids in the pathogenesis of BHS (1-4). Several studies found 
significantly higher rates of iron deficiency anemia in children with 
BHS than in healthy children. Indeed, several studies suggest an 
association between BHS and anemia in children (2, 3, 21). Mo-
can et al. (21) followed 91 children aged 6–40 months and found 
that 69% of patients had iron deficiency anemia. Yilmaz et al. (16) 
revealed that approximately half of the 165 children with BHS 
also had iron deficiency anemia Interestingly, results from several 
studies found that iron supplementation in anemic or iron-deficient 
patients appeared to reduce the frequency of BHS, with one clini-
cal trial  indicating complete remission of spells in 32%–52% of 
patients (2, 3). In contrast, Azab et al. (22) found that patients with 
BHS had no significant statistical differenceregarding anemia and 
had low SI compared with controls. They suggested that because 
no other types of anemia were associated with BHS, these spells 
were related to iron and not anemia. However, iron deficiency is 
not the only factor responsible for BHS, because not all children 
with BHS were iron deficient at baseline in the present study. In 
addition, it remains to be determined why children with BHS who 
were not iron deficient responded to iron treatment (21). Colina 
et al. (23) suggested that BHS occurs in children without iron de-
ficiency andthat the other causes of anemia appear to exert an 
effect on BHS.We found that the mean Hb level was significantly 
lower in the BHS group than in the control group, but there was 
no statistically significant correlation in SI and MCV levels between 
two groups. Children with low Hb levels have been found to have 
decreased cerebral oxygen transport capacity, making them more 
susceptible to the chain of events leading to loss of consciousness 
during BHS, which supports the hypothesis that low serum Hb lev-
els triggers BHS. Further studies are needed to elucidate whether 
serum Hb and SI levels or other types of anemia are involved in 
triggering loss of consciousness in patients with BHS.
Many factors may play a role in the etiopathogenesis of BHS. Kahn 
et al. (24) hypothesized that functional brainstem disturbances and 
immature breathing controls were involved in the occurrence of 
BHS. However, autonomic dysregulation has been implicated as a 
major component involved in the pathophysiology of these events 
with regard to BHS (25). The autonomic nervous system consists 
of two interacting systems: the sympathetic and parasympathetic 
systems. The sympathetic nervous system releases norepinephrine 
and epinephrine, which are responsible for the cascade of reac-
tions associated with stress, whereas the parasympathetic nervous 
system releases acetylcholine. The stimulation of the sympathetic 
nervous system also causes an increase in the glucose level re-
leased from the liver into the bloodstream; increase in the heart 
rate, myocardial contractility, pupil and bronchiole dilatation, blad-
der relaxation, blood vessel constriction, sweat secretion, inhibition 
of peristalsis; and increase in the renin secretion by the kidneys. 
In contrast, parasympathetic system stimulation decreases heart 
rate and constricts the pupils; increases secretion of the glands; 
increases peristalsis; and constricts bronchioles (26). It has been 
shown that during heart failure or after myocardial infarction, sym-
pathetic dominance occurs, which may trigger lethal arrhythmias. 
The sympathovagal imbalance is reflected by reduced HRV, which 
is a diagnostic factor for assessing autonomic dysfunction. In cya-
notic BHS spells, increased sympathetic activity occurs, whereas in 
pallid BHS spells, increased parasympathetic activity is seen as an 
autonomic regulation disorder (22).
Serum electrolytes levels, such as Na, K, Mg, and Ca levels, can 
affect HRV. Bobkowski et al. (27) evaluated the relationship be-
tween serum electrolyte levels and HRV in children with mitral 
valve prolapse and found that Mg levels positively correlated with 
parasympathetic indices and negatively correlated with sympa-
thetic indices. Mg is an important cation and is a cofactor in more 
than 300 enzymatic reactions in the body. It is also important for 
bone stability, muscular relaxation, neurotransmission, enzymatic 
reactions, and many other physiological and cellular functions. Mg 
deficiency contributes to the pathogenesis of several cardiovascular 
diseases, including hypertension, vasospastic angina, and ventricu-
lar arrhythmia. In addition, recent clinical studies have revealed 
that Mg protects the brain from ischemic damage, although the 
mechanism for neuroprotection afforded by Mg is yet to be fully 
elucidated (27). In addition, similar to the effects of Mg on vascu-
lature, it has been speculated that Mg also induces a decrease in 
the intracellular Ca. Therefore, it is hypothesized that the effects 
of Mg on Ca homeostasis in neural cells is a common mechanism 
between the sympathetic inhibitory and neuroprotective actions 
of Mg (12). Murasato et al. (12) suggested that Mg deficiency in-
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duced sympathetic excitation and enhanced the sensitivity of the 
sinus node to autonomic regulation, as Mg was shown toattenu-
ate sympathetic tone, primarily by inhibiting N-type Ca channels. 
Furthermore, Devisetty et al. (13) concluded that decreased serum 
Ca levels caused disturbances in the autonomic nervous system. 
The effects of Ca on HRV may be attributed to the role of Ca 
in modulating cardiac muscle excitability and blood pressure. Ca 
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Table 1. Age and laboratory findings of the study groups
 BHS Control group p
Age (years) 2.0±1.3 2.0±1.2 0.167
Hb(g/dL) 11.5±1.01 11.5±0.81 0.039
WBC(×10) 10.8±3.12 10.8±3.96 0.505
Htc(%) 35.0±2.55 35.8±2.68 0.131
MCV(f/L) 76.1±6.56 76.9±5.89 0.791
RBC(mm3) 4.59±0.37 4.58±0.39 0.994
MCH(pg/hc) 25.2±2.34 25.9±2.68 0.148
MCHC(g/dL) 33.1±1.39 33.6±1.17 0.001
SI(μg/dL) 57.9±42.9 56.4±27.3 0.428
SIBP(μg/dL) 330.6±61.9 343.3±49.0 0.083
Mg(mg/dL) 2.1±0.15 2.1±0.18 0.189
Ca(mg/dL) 9.9±0.57 10.2±0.39 0.001
P(mg/dL) 5.13±0.76 5.40±0.59 0.007
ALP (U/L) 216.3±59.7 211.8±73.7 0.310
RDW(%) 16.1±2.5 16.2±2.5 0.235
Ca/Mg ratio 4.73±0.35 4.78±0.38 0.403
BHS; breath-holding spells, Hb; hemoglobin, MCV; mean corpuscular 
volume, SI; serum iron, SIBP; serum iron binding protein, Mg; 
magnesium, Ca; calcium, P; phosphorus, ALP; alkaline phosphatase, 
htc; hematocrit, WBC; white blood cell, RBC; red blood cell, RDW; 
red cell distribution width, ALP; alkaline phosphatase, MCH; mean 
corpuscular hemoglobin, MCHC; mean corpuscular hemoglobin level
Figure 2. Comparison of serum P levels in the BHS group and 
in control group
Abbreviations: BHS; breath-holding spells, POS: phosphorus
Figure 3. Comparison of serum Mg levels in the BHS group 
and in control group
Abbreviations: BHS; breath-holding spells, Mg: magnesium
Figure 4. Comparison of serum Ca/Mg ratio in the BHS group 
and in control group
Abbreviations:: BHS; breath-holding spells
Figure 1. Comparison of serum Ca levels in the BHS group 
and in control group
Abbreviations: BHS; breath-holding spells, CA: calcium
supplementation has been proven to have hypotensive effects, par-
ticularly on systolic blood pressure, and therefore also affects HRV. 
In addition, Mg deficiency induced excessive catecholamine release 
and high sympathetic tone, which impaired baroreflex control of 
sympathetic nerves and reduced baroreflex-related oscillation, lead-
ing to a blunted baroreflex and enhanced heart rate response to 
stress (13). Several clinical investigations have identified a possible 
relationship between autonomic dysregulation and BHS. Kolkiran 
et al. (25) confirmed the presence of autonomic dysregulation in 
children with BHS and found that respiratory sinus arrhythmia and 
asystole frequency during BHS spells were higher in patients with 
pallid BHS. Akalin et al. (6) also determined that QT dispersion 
was increased in patients with BHS, and they speculated that in-
creased QTc dispersion in pallid BHS may be the result of the 
presence of more serious autonomic dysfunctions in this group (6). 
Previous reports also suggested that there is a centrally mediated 
sympathetic autonomic reflex hyperactivity in cyanotic BHS and 
a centrally mediated parasympathetic reflex hyperactivity in pallid 
BHS (1, 25). Considering the significant relationship between the 
autonomic nervous system and BHS, the present study was de-
signed to evaluate the association of serum Ca and Mg levels with 
BHS. Kim et al. (28) found that Mg levels and Ca/Mg ratio were 
associated with HRV. However, in the present study, no statistical 
differences were found in the mean Mg level between the BHS and 
control groups. Furthermore, there was no significant difference in 
the proportions of Ca/Mg between these two groups. Kim et al. 
(28) found that the mean heart rate tended to increase from the 
lowest to the highest tertile of Ca levels, whereas the mean hear 
trate decreased significantly with increasing Mg levels. In contrast, 
although serum Ca and P levels were in the normal range in both 
the BHS and control groups in our study, children with BHS had 
significantly lower mean serum Ca and P levels than healthy con-
trols. Based on these findings, we suggest that low serum Ca and 
P levels trigger BHS in children. We did not investigate and com-
pare the mean serum vitamin D levels and parathyroid hormone 
levels in the present study, and therefore, we cannot comment 
on a possible role of vitamin D and parathyroid hormone in the 
etiopathogenesis of BHS. Mann et al. (29) found that low serum 
levels of vitamin D were possibly associated with a decline in cardio 
protective vagal tone in response to an acute vascular stressor, 
largely through the action of the active 1,25-dihydroxyvitamin D 
metabolite. In contrast, Burt et al. (30) showed that 25-hydroxyvi-
tamin D was not significantly associated with baroreflex sensitivity 
or heart rate spectral parameters, suggesting that it does not alter 
basal parasympathetic nervous system activity. Therefore, further 
studies are needed to elucidate whether BHS is involved in this 
process in patients with low Ca and P levels.
CONCLUSION
To the best of our knowledge, this is the first study in English-
language medical literature to report serum Mg, Ca, and P levels 
in children with and without BHS. It is also the first study reporting 
serum Ca/Mg ratio levels in these patient groups. Although Ca and 
P levels were within normal ranges in both groups, the mean Ca 
and P levels were significantly lower in the BHS group than in the 
control group. Therefore, these results suggest that low serum Ca 
and P levels reduce the threshold for BHS and thus are risk factors 
for BHS. Further large-scale studies are warranted to explain the 
roles Mg, Ca, and P play in BHS.
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